J
Jin Wang
Researcher at Fudan University
Publications - 104
Citations - 3521
Jin Wang is an academic researcher from Fudan University. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 27, co-authored 95 publications receiving 2800 citations. Previous affiliations of Jin Wang include University of Texas System & China Medical University (PRC).
Papers
More filters
Journal ArticleDOI
MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease
Jin Wang,Jinyun Chen,Ping Chang,Aimee Leblanc,Donghui Li,James L. Abbruzzesse,Marsha L. Frazier,Ann M. Killary,Subrata Sen +8 more
TL;DR: Observations show the feasibility of developing plasma miRNA profiling as a sensitive and specific blood-based biomarker assay for pancreatic cancer that has the potential of translation to the clinic with additional improvements in the future.
Journal ArticleDOI
MicroRNA as Biomarkers and Diagnostics
TL;DR: Some of the clinical evidence for the use of miRNAs as biomarkers in diagnostics is summarized and some general perspectives on their use in clinical situations are provided.
Journal ArticleDOI
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice
Christopher Corpe,Hongbin Tu,Peter Eck,Jin Wang,Robert Faulhaber-Walter,Jurgen Schnermann,Sam Margolis,Sebastian J. Padayatty,He Sun,Yaohui Wang,Robert L. Nussbaum,Michael Graham Espey,Mark Levine +12 more
TL;DR: Findings indicate a key role for Slc23a1 in renal ascorbate absorption and perinatal survival and reveal regulation of vitamin C biosynthesis in mice.
Journal ArticleDOI
Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
TL;DR: The development of tumor-specific miRNA signatures as cancer biomarkers detectable in malignant cells and body fluids should help with early detection and more effective therapeutic intervention for individual patients.
Journal ArticleDOI
Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.
TL;DR: The latest findings on the role of circulating miRNAs as potential minimally invasive diagnostic and prognostic biomarkers for HCC are summarized.